Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice

Inclusion Criteria: * Patients with an indication to an ablation procedure of Atrial Fibrillation according to current international and local guidelines (and future revisions), existing IFU and per physician discretion * Patients who are willing and capable of providing informed consent, participating in all testing at an approved clinical investigational center. * Patients whose age is 18 years or above, and of legal age to give informed consent specific to state and national law. Exclusion Criteria: * Patients who are currently enrolled in another investigational study or registry that would directly interfere with the current study, except when the subject is participating in a mandatory governmental registry, or a purely observational registry with no associated treatments * Patients who are unwilling or unable to sign an authorization to use and disclose health information or an Informed Consent. * Patients unavailable or not willing to complete follow up visits and examination for the duration of the study at the center. * Life expectancy ≤ 12 months per physician judgment. * Unrecovered/unresolved Adverse Events from any previous invasive procedure; * Women of childbearing potential who are, or plan to become, pregnant during the time of the study (method of assessment upon physician's discretion) * Left atrial thrombus in pre-procedure imaging within 4 weeks of the ablation procedure. * AF secondary to electrolyte imbalance, thyroid disease or reversible non- cardiac cause